Clinical Trial Update: A Study on Rheumatoid Arthritis Patients Treated With Rituximab

View source ↗

Summary

This document reports on a completed clinical trial evaluating rituximab in patients with rheumatoid arthritis. The sponsor listed is Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED